Document:

Exhibit A
	
         

         
	WARRANT	 
	NO. ___	AMERICAN STRATEGIC MINERALS CORP.	________ Shares
	
         

         
	 	 

WARRANT TO PURCHASE COMMON
STOCK

VOID AFTER 5:30 P.M., EASTERN 

TIME, ON THE EXPIRATION DATE

THIS WARRANT AND ANY SHARES
ACQUIRED UPON THE EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”),
AND MAY NOT BE SOLD, PLEDGED, HYPOTHECATED, DONATED OR OTHERWISE TRANSFERRED WITHOUT COMPLIANCE WITH THE REGISTRATION OR QUALIFICATION
PROVISIONS OF APPLICABLE FEDERAL AND STATE SECURITIES LAWS OR APPLICABLE EXEMPTIONS THEREFROM.

FOR VALUE RECEIVED,
AMERICAN STRATEGIC MINERALS CORP., a Nevada corporation (the “Company”), hereby agrees to sell upon the terms
and on the conditions hereinafter set forth, but no later than 5:30 p.m., Eastern Time, on the Expiration Date (as hereinafter
defined) to ________________ or registered assigns (the “Holder”), under the terms as hereinafter set
forth, __________________ (_____________) fully paid and non-assessable shares of the Company’s Common Stock, par
value $0.0001 per share (the “Warrant Stock”), at a purchase price of $0.60 per share (the “Warrant
Price”), pursuant to this warrant (this “Warrant”). The number of shares of Warrant Stock to be so
issued and the Warrant Price are subject to adjustment in certain events as hereinafter set forth. The term “Common Stock”
shall mean, when used herein, unless the context otherwise requires, the stock and other securities and property at the time receivable
upon the exercise of this Warrant. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in
that certain Subscription Agreement (the “Subscription Agreement”), dated as of the date hereof, entered into
by the Company, the Holder and the other signatories thereto.

1.                  
Exercise of Warrant.

a.                  
At any time after a Registration Statement registering shares of Warrant Stock is required
to be filed or declared effective that has not as of the date of exercise been filed or declared effective, the Holder may exercise
this Warrant according to its terms by surrendering this Warrant to the Company at the address set forth in Section 11, the Notice
of Exercise attached hereto having then been duly executed by the Holder, accompanied by cash, certified check or bank draft in
payment of the purchase price, in lawful money of the United States of America, for the number of shares of the Warrant Stock specified
in the Notice of Exercise, or as otherwise provided in this Warrant, prior to 5:30 p.m., Eastern Time, on __________________, 20__
(the “Expiration Date”).

b.                  
Cashless Exercise. This Warrant may be exercised, in whole or in part, at such time
by means of a “cashless exercise” in which the Holder shall be entitled to receive a certificate for the number of
shares of Warrant Stock equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:

(A) =the closing price of the Company’s
common stock on the trading day immediately preceding the date on which Holder elects to exercise this Warrant by means of a “cashless
exercise,” as set forth in the applicable Notice of Exercise;

 

(B) =the Exercise Price of this
Warrant, as adjusted hereunder; and

 

(X) =the number of shares of Warrant
Stock that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by
means of a cash exercise rather than a cashless exercise.

 

     

     

    
 

c.                   
This Warrant may be exercised in whole or in part so long as any exercise in part hereof would
not involve the issuance of fractional shares of Warrant Stock. If exercised in part, the Company shall deliver to the Holder a
new Warrant, identical in form, in the name of the Holder, evidencing the right to purchase the number of shares of Warrant Stock
as to which this Warrant has not been exercised, which new Warrant shall be signed by the Chairman, Chief Executive Officer or
President and the Secretary or Assistant Secretary of the Company. The term Warrant as used herein shall include any subsequent
Warrant issued as provided herein.

d.                  
No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. The Company shall pay cash in lieu of fractions with respect to the Warrants based upon the fair market value
of such fractional shares of Common Stock (which shall be the closing price of such shares on the exchange or market on which the
Common Stock is then traded) at the time of exercise of this Warrant.

e.                   
In the event of any exercise of the rights represented by this Warrant, a certificate or certificates
for the Warrant Stock so purchased, registered in the name of the Holder, shall be delivered to the Holder within three (3) trading
days after such rights shall have been so exercised. The person or entity in whose name any certificate for the Warrant Stock is
issued upon exercise of the rights represented by this Warrant shall for all purposes be deemed to have become the holder of record
of such shares immediately prior to the close of business on the date on which the Warrant was surrendered and payment of the Warrant
Price and any applicable taxes was made, irrespective of the date of delivery of such certificate, except that, if the date of
such surrender and payment is a date when the stock transfer books of the Company are closed, such person shall be deemed to have
become the holder of such shares at the opening of business on the next succeeding date on which the stock transfer books are open.
The Company shall pay any and all documentary stamp or similar issue or transfer taxes payable in respect of the issue or delivery
of shares of Common Stock on exercise of this Warrant.

f. Compensation
for Buy-In on Failure to Timely Deliver Certificates Upon Exercise. In addition to any other rights available to the Holder, if
the Company fails to cause its transfer agent to transmit to the Holder a certificate or the certificates representing the Warrant
Stock pursuant to an exercise within three trading days from the date of such exercise, and if after such date the Holder is required
by its broker to purchase (in an open market transaction or otherwise) or the Holder’s brokerage firm otherwise purchases,
shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Stock which the Holder anticipated receiving
upon such exercise (a “Buy-In”), then the Company shall (A) pay in cash to the Holder the amount, if any, by
which (x) the Holder’s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased
exceeds (y) the amount obtained by multiplying (1) the number of shares of Warrant Stock that the Company was required to deliver
to the Holder in connection with the exercise at issue times (2) the price at which the sell order giving rise to such purchase
obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent number
of shares of Warrant Stock for which such exercise was not honored (in which case such exercise shall be deemed rescinded) or deliver
to the Holder the number of shares of Common Stock that would have been issued had the Company timely complied with its exercise
and delivery obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase price of $11,000
to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving rise to such
purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay the
Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the
Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder’s right
to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific
performance and/or injunctive relief with respect to the Company’s failure to timely deliver certificates representing shares
of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.

2.                  
Disposition of Warrant Stock and Warrant.

a.                  
The Holder hereby acknowledges that this Warrant and any Warrant Stock purchased pursuant
hereto are, as of the date hereof, not registered: (i) under the Securities Act of 1933, as amended (the “Act”),
on the ground that the issuance of this Warrant is exempt from registration under Section 4(2) of the Act as not involving any
public offering or under Rule 903 of Regulation S promulgated under the Act or (ii) under any applicable state securities law because
the issuance of this Warrant does not involve any public offering; and that the Company’s reliance on the Section 4(2) exemption
of the Act or Rule 903 of Regulation S promulgated under the Act, as the case may be, and under applicable state securities laws
is predicated in part on the representations hereby made to the Company by the Holder that it is acquiring this Warrant and will
acquire the Warrant Stock for investment for its own account, with no present intention of dividing its participation with others
or reselling or otherwise distributing the same, subject, nevertheless, to any requirement of law that the disposition of its property
shall at all times be within its control.

     

     

    
 

The Holder hereby
agrees that it will not sell or transfer all or any part of this Warrant and/or Warrant Stock unless and until it shall first have
given notice to the Company describing such sale or transfer and furnished to the Company either (i) an opinion, reasonably satisfactory
to counsel for the Company, of counsel (skilled in securities matters, selected by the Holder and reasonably satisfactory to the
Company) to the effect that the proposed sale or transfer may be made without registration under the Act and without registration
or qualification under any state law, or (ii) an interpretative letter from the Securities and Exchange Commission to the effect
that no enforcement action will be recommended if the proposed sale or transfer is made without registration under the Act.

b.                  
If, at the time of issuance of the shares issuable upon exercise of this Warrant, no registration
statement is in effect with respect to such shares under applicable provisions of the Act, unless cashless exercise is properly
elected by the Holder and an applicable exemption from registration is available and the Company provided with an opinion of counsel
acceptable to the Company that registration is not then required, in which case the certificate representing the Warrant Stock
shall not bear any restrictive legend, the Company may at its election require that the Holder provide the Company with written
reconfirmation of the Holder’s investment intent and that any stock certificate delivered to the Holder of a surrendered
Warrant shall bear legends reading substantially as follows:

“THE SHARES REPRESENTED
BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AND MAY NOT BE SOLD, TRANSFERRED, PLEDGED OR OTHERWISE
DISPOSED OF IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 OR AN OPINION OF COUNSEL SATISFACTORY
TO THE ISSUER OF THIS CERTIFICATE THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT.”

In addition, so long as the foregoing
legend may remain on any stock certificate delivered to the Holder, the Company may maintain appropriate “stop transfer”
orders with respect to such certificates and the shares represented thereby on its books and records and with those to whom it
may delegate registrar and transfer functions.

3.                  
Reservation of Shares. The Company hereby agrees that at all times there shall be reserved
for issuance upon the exercise of this Warrant such number of shares of its Common Stock as shall be required for issuance upon
exercise of this Warrant. The Company further agrees that all shares which may be issued upon the exercise of the rights represented
by this Warrant will be duly authorized and will, upon issuance and against payment of the exercise price, be validly issued, fully
paid and non-assessable, free from all taxes, liens, charges and preemptive rights with respect to the issuance thereof, other
than taxes, if any, in respect of any transfer occurring contemporaneously with such issuance and other than transfer restrictions
imposed by federal and state securities laws.

4.                  
Exchange, Transfer or Assignment of Warrant. This Warrant is exchangeable, without
expense, at the option of the Holder, upon presentation and surrender hereof to the Company or at the office of its stock transfer
agent, if any, for other Warrants of different denominations, entitling the Holder or Holders thereof to purchase in the aggregate
the same number of shares of Common Stock purchasable hereunder. Upon surrender of this Warrant to the Company or at the office
of its stock transfer agent, if any, with the Assignment Form annexed hereto duly executed and funds sufficient to pay any transfer
tax, the Company shall, without charge, execute and deliver a new Warrant in the name of the assignee named in such instrument
of assignment and this Warrant shall promptly be canceled. This Warrant may be divided or combined with other Warrants that carry
the same rights upon presentation hereof at the office of the Company or at the office of its stock transfer agent, if any, together
with a written notice specifying the names and denominations in which new Warrants are to be issued and signed by the Holder hereof.

     

     

    
 

5.                  
Capital Adjustments. This Warrant is subject to the following further provisions:

a.                  
Fundamental Transaction. If, at any time while this Warrant is outstanding, (A) the Company
effects any merger or consolidation of the Company with or into another entity, (B) the Company effects any sale of all or substantially
all of its assets in one or a series of related transactions, (C) any tender offer or exchange offer (whether by the Company or
another entity) is completed pursuant to which holders of Common Stock are permitted to tender or exchange their shares for other
securities, cash or property, (D) the Company consummates a stock purchase agreement or other business combination (including,
without limitation, a reorganization, recapitalization, or spin-off) with one or more persons or entities whereby such other persons
or entities acquire more than the 50% of the outstanding shares of Common Stock (not including any shares of Common Stock held
by such other persons or entities making or party to, or associated or affiliated with the other persons or entities making or
party to, such stock purchase agreement or other business combination), (E) any "person" or "group" (as these
terms are used for purposes of Sections 13(d) and 14(d) of the 1934 Act) is or shall become the "beneficial owner" (as
defined in Rule 13d-3 under the 1934 Act), directly or indirectly, of 50% of the aggregate Common Stock of the Company, or (F)
the Company effects any reclassification of the Common Stock or any compulsory share exchange pursuant to which the Common Stock
is effectively converted into or exchanged for other securities, cash or property (in any such case, a "Fundamental Transaction"),
then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would
have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the
Holder, (a) upon exercise of this Warrant, the number of shares of Common Stock of the successor or acquiring corporation or of
the Company, if it is the surviving corporation, and any additional consideration (the "Alternate Consideration") receivable
upon or as a result of such reorganization, reclassification, merger, consolidation or disposition of assets by a Holder of the
number of shares of Common Stock for which this Warrant is exercisable immediately prior to such event or (b) if the Company is
acquired in (1) a transaction where the consideration paid to the holders of the Common Stock consists solely of cash, (2) a “Rule
13e-3 transaction” as defined in Rule 13e-3 under the 1934 Act, or (3) a transaction involving a person or entity not traded
on a national securities exchange, the Nasdaq Global Select Market, the Nasdaq Global Market or the Nasdaq Capital Market, cash
equal to the Black-Scholes Value. For purposes of any such exercise, the determination of the Purchase Price shall be appropriately
adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share
of Common Stock in such Fundamental Transaction, and the Company shall apportion the Purchase Price among the Alternate Consideration
in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of
Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the
Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following
such Fundamental Transaction. To the extent necessary to effectuate the foregoing provisions, any successor to the Company or surviving
entity in such Fundamental Transaction shall issue to the Holder a new warrant consistent with the foregoing provisions and evidencing
the Holder's right to exercise such warrant into Alternate Consideration. The terms of any agreement pursuant to which a Fundamental
Transaction is effected shall include terms requiring any such successor or surviving entity to comply with the provisions of this
Section 3.1 and insuring that this Warrant (or any such replacement security) will be similarly adjusted upon any subsequent transaction
analogous to a Fundamental Transaction. “Black-Scholes Value” shall be determined in accordance with the Black-Scholes
Option Pricing Model obtained from the “OV” function on Bloomberg L.P. using (i) a price per share of Common Stock
equal to the VWAP of the Common Stock for the Trading Day immediately preceding the date of consummation of the applicable Fundamental
Transaction, (ii) a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the remaining term of
this Warrant as of the date of such request and (iii) an expected volatility equal to the 100 day volatility obtained from the
HVT function on Bloomberg L.P. determined as of the Trading Day immediately following the public announcement of the applicable
Fundamental Transaction.

     

     

    
 

b.                  
Recapitalization, Reclassification and Succession. If any recapitalization of the Company
or reclassification of its Common Stock or any merger or consolidation of the Company into or with a corporation or other business
entity, or the sale or transfer of all or substantially all of the Company's assets or of any successor corporation's assets to
any other corporation or business entity (any such corporation or other business entity being included within the meaning of the
term "successor corporation") shall be effected, at any time while this Warrant remains outstanding and unexpired, then,
as a condition of such recapitalization, reclassification, merger, consolidation, sale or transfer, lawful and adequate provision
shall be made whereby the Holder of this Warrant thereafter shall have the right to receive upon the exercise hereof as provided
in Section 1 and in lieu of the shares of Common Stock immediately theretofore issuable upon the exercise of this Warrant, such
shares of capital stock, securities or other property as may be issued or payable with respect to or in exchange for a number of
outstanding shares of Common Stock equal to the number of shares of Common Stock immediately theretofore issuable upon the exercise
of this Warrant had such recapitalization, reclassification, merger, consolidation, sale or transfer not taken place, and in each
such case, the terms of this Warrant shall be applicable to the shares of stock or other securities or property receivable upon
the exercise of this Warrant after such consummation.

c.                   
Subdivision or Combination of Shares. If the Company at any time while this Warrant
remains outstanding and unexpired shall subdivide or combine its Common Stock, the number of shares of Warrant Stock purchasable
upon exercise of this Warrant and the Warrant Price shall be proportionately adjusted.

d.                  
Stock Dividends and Distributions. If the Company at any time while this Warrant is
outstanding and unexpired shall issue or pay the holders of its Common Stock, or take a record of the holders of its Common Stock
for the purpose of entitling them to receive, a dividend payable in, or other distribution of, Common Stock, then (i) the Warrant
Price shall be adjusted in accordance with Section 5(f) and (ii) the number of shares of Warrant Stock purchasable upon exercise
of this Warrant shall be adjusted to the number of shares of Common Stock that the Holder would have owned immediately following
such action had this Warrant been exercised immediately prior thereto.

e.                   
Stock and Rights Offering to Shareholders. If the Company shall at any time after the
date of issuance of this Warrant distribute to all holders of its Common Stock any shares of capital stock of the Company (other
than Common Stock) or evidences of its indebtedness or assets (excluding cash dividends or distributions paid from retained earnings
or current year’s or prior year’s earnings of the Company) or rights or warrants to subscribe for or purchase any of
its securities (excluding those referred to in the immediately preceding paragraph) (any of the foregoing being hereinafter in
this paragraph called the “Securities”), then in each such case, the Company shall reserve shares or other units of
such Securities for distribution to the Holder upon exercise of this Warrant so that, in addition to the shares of the Common Stock
to which such Holder is entitled, such Holder will receive upon such exercise the amount and kind of such Securities which such
Holder would have received if the Holder had, immediately prior to the record date for the distribution of the Securities, exercised
this Warrant.

f.                   
Warrant Price Adjustment. Except as otherwise provided herein, whenever the number
of shares of Warrant Stock purchasable upon exercise of this Warrant is adjusted, as herein provided, the Warrant Price payable
upon the exercise of this Warrant shall be adjusted to that price determined by multiplying the Warrant Price immediately prior
to such adjustment by a fraction (i) the numerator of which shall be the number of shares of Warrant Stock purchasable upon exercise
of this Warrant immediately prior to such adjustment, and (ii) the denominator of which shall be the number of shares of Warrant
Stock purchasable upon exercise of this Warrant immediately thereafter.

g.                   
Certain Shares Excluded. The number of shares of Common Stock outstanding at any given
time for purposes of the adjustments set forth in this Section 5 shall exclude any shares then directly or indirectly held in the
treasury of the Company.

h.                  
Deferral and Cumulation of De Minimis Adjustments. The Company shall not be required
to make any adjustment pursuant to this Section 5 if the amount of such adjustment would be less than one percent (1%) of the Warrant
Price in effect immediately before the event that would otherwise have given rise to such adjustment. In such case, however, any
adjustment that would otherwise have been required to be made shall be made at the time of and together with the next subsequent
adjustment which, together with any adjustment or adjustments so carried forward, shall amount to not less than one percent (1%)
of the Warrant Price in effect immediately before the event giving rise to such next subsequent adjustment.

     

     

    
 

i.                    
Duration of Adjustment. Following each computation or readjustment as provided in this
Section 5, the new adjusted Warrant Price and number of shares of Warrant Stock purchasable upon exercise of this Warrant shall
remain in effect until a further computation or readjustment thereof is required. 

6.                  
Removed and Reserved. 

7.                  
Limitation on Exercises. The Company shall not effect the exercise of this Warrant,
and the Holder shall not have the right to exercise this Warrant, to the extent that after giving effect to such exercise, the
Holder (together with such Holder’s affiliates) would beneficially own in excess of 4.99% of the shares of Common Stock outstanding
immediately after giving effect to such exercise. For purposes of the foregoing sentence, the aggregate number of shares of Common
Stock beneficially owned by such Holder and its affiliates shall include the number of shares of Common Stock issuable upon exercise
of this Warrant with respect to which the determination of such sentence is being made, but shall exclude shares of Common Stock
which would be issuable upon (A) exercise of the remaining, unexercised portion of this Warrant beneficially owned by such Holder
and its affiliates and (B) exercise or conversion of the unexercised or unconverted portion of any other securities of the Company
beneficially owned by such Person and its affiliates (including, without limitation, any convertible notes or convertible preferred
stock or warrants) subject to a limitation on conversion or exercise analogous to the limitation contained herein. Except as set
forth in the preceding sentence, for purposes of this paragraph, beneficial ownership shall be calculated in accordance with Section
13(d) of the Securities Exchange Act of 1934, as amended. To the extent that the limitation contained in this Section 7 applies,
the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any
affiliate) and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission
of a Notice of Exercise shall be deemed to be the Holder’s determination of whether this Warrant is exercisable (in relation
to other securities owned by the Holder together with any affiliate) and of which portion of this Warrant is exercisable, in each
case subject to such aggregate percentage limitation, and the Company shall have no obligation to verify or confirm the accuracy
of the determination. For purposes of this Warrant, in determining the number of outstanding shares of Common Stock, the Holder
may rely on the number of outstanding shares of Common Stock as reflected in (1) the Company's most recent Form 10-K, Form 10-Q,
Current Report on Form 8-K or other public filing with the Securities and Exchange Commission, as the case may be, (2) a more recent
public announcement by the Company or (3) any other notice by the Company setting forth the number of shares of Common Stock outstanding.
For any reason at any time, upon the written or oral request of the Holder, the Company shall within one (1) business day confirm
orally and in writing to the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding
shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including
this Warrant, by the Holder and its affiliates since the date as of which such number of outstanding shares of Common Stock was
reported. The restriction described in this Section 7 may be waived, in whole or in part, upon sixty-one (61) days prior notice
from the Holder to the Company to increase such percentage up to 9.99%, but not in excess of 9.99%. The
provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms
of this Section 7 to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended beneficial
ownership limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such
limitation.

8.                  
Notice to Holders.

a.                  
Notice of Record Date. In case:

     

     

    
 

(i)                  
the Company shall take a record of the holders of its Common Stock (or other stock or securities
at the time receivable upon the exercise of this Warrant) for the purpose of entitling them to receive any dividend (other than
a cash dividend payable out of earned surplus of the Company) or other distribution, or any right to subscribe for or purchase
any shares of stock of any class or any other securities, or to receive any other right;

(ii)                
of any capital reorganization of the Company, any reclassification of the capital stock of
the Company, any consolidation with or merger of the Company into another corporation, or any conveyance of all or substantially
all of the assets of the Company to another corporation; or

(iii)               
of any voluntary dissolution, liquidation or winding-up of the Company;

then, and in each such case, the
Company will mail or cause to be mailed to the Holder hereof at the time outstanding a notice specifying, as the case may be, (i)
the date on which a record is to be taken for the purpose of such dividend, distribution or right, and stating the amount and character
of such dividend, distribution or right, or (ii) the date on which such reorganization, reclassification, consolidation, merger,
conveyance, dissolution, liquidation or winding-up is to take place, and the time, if any, is to be fixed, as of which the holders
of record of Common Stock (or such stock or securities at the time receivable upon the exercise of this Warrant) shall be
entitled to exchange their shares of Common Stock (or such other stock or securities) for securities or other property deliverable
upon such reorganization, reclassification, consolidation, merger, conveyance, dissolution or winding-up. Such notice shall be
mailed at least thirty (30) days prior to the record date therein specified, or if no record date shall have been specified therein,
at least thirty (30) days prior to such specified date, provided, however, failure to provide any such notice shall not affect
the validity of such transaction.

b.                  
Certificate of Adjustment. Whenever any adjustment shall be made pursuant to Section
5 hereof, the Company shall promptly make a certificate signed by its Chairman, Chief Executive Officer, President, Vice President,
Chief Financial Officer or Treasurer, setting forth in reasonable detail the event requiring the adjustment, the amount of the
adjustment, the method by which such adjustment was calculated and the Warrant Price and number of shares of Warrant Stock
purchasable upon exercise of this Warrant after giving effect to such adjustment, and shall promptly cause copies of such certificates
to be mailed (by first class mail, postage prepaid) to the Holder of this Warrant.

9.                  
Loss, Theft, Destruction or Mutilation. Upon receipt by the Company of evidence satisfactory
to it, in the exercise of its reasonable discretion, of the ownership and the loss, theft, destruction or mutilation of this Warrant
and, in the case of loss, theft or destruction, of indemnity reasonably satisfactory to the Company and, in the case of mutilation,
upon surrender and cancellation thereof, the Company will execute and deliver in lieu thereof, without expense to the Holder, a
new Warrant of like tenor dated the date hereof.

10.               
Warrant Holder Not a Stockholder. The Holder of this Warrant, as such, shall not be
entitled by reason of this Warrant to any rights whatsoever as a stockholder of the Company.

11.               
Notices. Any notice required or contemplated by this Warrant shall be deemed to have
been duly given if transmitted by registered or certified mail, return receipt requested, or nationally recognized overnight delivery
service, to the Company at its principal executive offices located at American Strategic Minerals Corp., c2331 Mill Road,
Suite 100, Alexandria, VA 22314 Attention: Doug Croxall, CEO, or to the Holder at the name and address set forth in the Warrant
Register maintained by the Company.

12.               
Choice of Law. THIS WARRANT IS ISSUED UNDER AND SHALL FOR ALL PURPOSES BE GOVERNED
BY AND CONSTRUED IN ACCORDANCE WITH THE INTERNAL LAWS OF THE STATE OF NEW YORK, WITHOUT GIVING EFFECT TO PRINCIPLES OF CONFLICTS
OF LAW.

     

     

    
 

13.               
Jurisdiction and Venue. The Company and Holder hereby agree that any dispute which
may arise between them arising out of or in connection with this Warrant shall be adjudicated before a court located in New York
County, New York and they hereby submit to the exclusive jurisdiction of the federal and state courts of the State of York located
in New York County with respect to any action or legal proceeding commenced by any party, and irrevocably waive any objection they
now or hereafter may have respecting the venue of any such action or proceeding brought in such a court or respecting the fact
that such court is an inconvenient forum, relating to or arising out of this Warrant or any acts or omissions relating to the sale
of the securities hereunder, and consent to the service of process in any such action or legal proceeding by means of registered
or certified mail, return receipt requested, in care of the address set forth herein or such other address as either party shall
furnish in writing to the other.

14.               
Amendment. This Warrant may be modified or amended or the provisions hereof waived
with the written consent signed by both (a) the Company and (b) holders of Warrants representing a majority of the Warrant Stock
then outstanding and not exercised.

     

     

    

IN WITNESS WHEREOF,
the Company has duly caused this Warrant to be signed on its behalf, in its corporate name and by its duly authorized officers,
as of this __ day of _____________________, 2012.

AMERICAN STRATEGIC MINERALS
CORP.

By:_______________________________

Name: Doug Croxall

Title: Chief Executive Officer

     

     

    

NOTICE OF EXERCISE

TO: American Strategic
Minerals Corp

			2331 Mill Road, Suite 100

			Alexandria, VA 22314

Attn: Doug Croxall, CEO

Tel: (___) ___-____

Fax: (___) ___-____

 

(1)                
The undersigned hereby elects to purchase ______________ shares of Warrant Stock of the Company
pursuant to the terms of the attached Warrant to Purchase Common Stock, and tenders herewith payment of the exercise price in full,
together with all applicable transfer taxes, if any. 

(2)                
Payment shall take the form of (check applicable box): 

[_]in
lawful money of the United States; or

[_]if
permitted, the cancellation of __________ shares of Warrant Stock in order to exercise this Warrant with respect to ____________
shares of Warrant Stock (using the closing price of Company’s common stock the previous trading day of $______ for this calculation),
in accordance with the formula and procedure set forth in subsection 1(b).

[_]if
permitted, the cancellation of such number of shares of Warrant Stock as is necessary, in accordance with the formula and procedure
set forth in subsection 1(b), to exercise this Warrant with respect to the maximum number of shares of Warrant Stock purchasable
pursuant to a cashless exercise. 

(3)                
Please issue a certificate or certificates representing said shares of Warrant Stock in the
name of the undersigned or in such other name as is specified below: 

                                                                                                                                                                         

 

The shares of Warrant
Stock shall be delivered to the following DWAC Account Number, if permitted, or by physical delivery of a certificate to:

                                                                                                                                                                         

                                                                                                                                                                         

                                                                                                                                                                         

 

(4)                
Accredited Investor. The undersigned is an “accredited investor” as defined
in Regulation D promulgated under the Securities Act of 1933, as amended or the undersigned satisfies the requirements under Regulation
S promulgated under the Securities Act of 1933, as amended.

     

     

    

[SIGNATURE OF HOLDER]

Name of Investing Entity:                                                                                                                                                                          

Signature of Authorized Signatory of Investing Entity:                                                                                                                       

Name and Title of Authorized Signatory:                                                                                                                                                

Date:                                                                                                                                                                                                              

     

     

    

ASSIGNMENT FORM 

(To assign the foregoing warrant, execute

this form and supply required information.

Do not use this form to exercise the warrant.)

FOR VALUE RECEIVED,
all of or   shares of the foregoing Warrant and all rights evidenced thereby are hereby assigned to

                                                           
whose address is

                                                                                             

                                                                                             

Dated:                              ,         

Holder’s Name:                                                                                                                                                                                           

Holder’s Signature:                                                                                                                                                                                    

Name and Title of Signatory:                                                                                                                                                                    

Holder’s Address:                                                                                                                                                                                      

Signature Guaranteed:                                                                                                                                                                                

NOTE: The signature to this Assignment
Form must correspond with the name as it appears on the face of the Warrant, without alteration or enlargement or any change whatsoever,
and must be guaranteed by a bank or trust company. Officers of corporations and those acting in a fiduciary or other representative
capacity should file proper evidence of authority to assign the foregoing Warrant.REGISTRATION RIGHTS AGREEMENT

 

THIS REGISTRATION
RIGHTS AGREEMENT (this “Agreement”) is made as of _________ 2012, among American Strategic Minerals Corp., a
Nevada corporation (the “Company”), and each signatory hereto (each, an “Investor” and collectively,
the “Investors”).

R E C I T A L S

WHEREAS, the Company
and the Investors are parties to Subscription Agreements (the “Subscription Agreements”), dated as of the date
hereof, as such may be amended and supplemented from time to time;

WHEREAS, the Investors’
obligations under the Subscription Agreements are conditioned upon certain registration rights under the Securities Act of 1933,
as amended (the “Securities Act”); and

WHEREAS, the Investors
and the Company desire to provide for the rights of registration under the Securities Act as are provided herein upon the execution
and delivery of this Agreement by such Investors and the Company.

NOW, THEREFORE,
in consideration of the promises, covenants and conditions set forth herein, the parties hereto hereby agree as follows:

1.      
Registration Rights.

1.1             
Definitions. As used in this Agreement, the following terms shall have the meanings
set forth below:

(a)                
“Commission” means the United States Securities and Exchange Commission.

(b)                
“Common Stock” means the Company’s common stock, par value $0.0001
per share.

(c)                
“Effectiveness Date” means the date that is ninety (90) days after the
Filing Date.

(d)                
“Exchange Act” means the Securities Exchange Act of 1934, as amended.

(e)                
“Filing Date” means the date that is ninety (90) days after the Trigger
Date.

(f)                 
 “Investor” means any person owning Registrable Securities who becomes
party to this Agreement by executing a counterpart signature page hereto, or other agreement in writing to be bound by the terms
hereof, which is accepted by the Company.

(g)                
The terms “register,” “registered” and “registration”
refer to a registration effected by preparing and filing a registration statement or similar document in compliance with the Securities
Act, and the declaration or ordering of effectiveness of such registration statement or document.

(h)                
“Registrable Securities” means any of the Shares or any securities issued
or issuable as (or any securities issued or issuable upon the conversion or exercise of any warrant, right or other security that
is issued as) a dividend or other distribution with respect to, or in exchange for, or in replacement of, the Shares; provided,
however, that Registrable Securities shall not include any securities of the Company that have previously been registered
and remain subject to a currently effective registration statement or which have been sold either pursuant to a registration statement
or Rule 144, or which have been sold in a private transaction in which the transferor’s rights under this Section 1
are not assigned, or which may be sold immediately without registration under the Securities Act and without volume restrictions
pursuant to Rule 144.

     

     

    
 

(i)                  
“Rule 144” means Rule 144 as promulgated by the Commission under the Securities
Act, as such Rule may be amended from time to time, or any similar successor rule that may be promulgated by the Commission.

(j)                 
“Rule 415” means Rule 415 as promulgated by the Commission under the Securities
Act, as such Rule may be amended from time to time, or any similar successor rule that may be promulgated by the Commission.

(k)                
 “Shares” means the shares of Common Stock (i) issued pursuant to the Subscription
Agreements, and (ii) underlying the Warrants.

(l)                  
“Trigger Date” means the Final Closing Date (as defined in the Subscription
Agreement).

(m)              
“Warrants” means the warrants to purchase Common Stock issued pursuant
to the Subscription Agreement.

1.2             
 Company Registration.

(a)                
On or prior to the Filing Date, the Company shall prepare and file with the Commission a registration
statement (the “Registration Statement”) covering the Registrable Securities for an offering to be made on a
continuous basis pursuant to Rule 415. The Registration Statement shall be on Form S-1 or, if the Company is so eligible, on Form
S-3 (except if the Company is not then eligible to register for resale the Registrable Securities on Form S-1 or Form S-3, as the
case may be, in which case such Registration Statement shall be on another appropriate form in accordance herewith) and shall contain
(unless otherwise directed by Investors holding an aggregate of at least 75% of the Registrable Securities on a fully diluted basis)
substantially the “Plan of Distribution” attached hereto as Annex A. The Company shall use its reasonable
best efforts to cause the Registration Statement to be declared effective under the Securities Act as soon as possible and, in
any event, by the Effectiveness Date. The Company shall use its reasonable best efforts to keep the Registration Statement continuously
effective under the Securities Act until all Registrable Securities covered by such Registration Statement have been sold, or may
be sold without the requirement to be in compliance with Rule 144(c)(1) and otherwise without restriction or limitation pursuant
to Rule 144, as determined by the counsel to the Company (the “Effectiveness Period”). 

(b)                
If a Registration Statement covering the Registrable Securities is not filed with the SEC
on or prior to the Filing Date, or not effective with the SEC prior to the Effectiveness Date, the Company will make payments to
the Investor, as liquidated damages and not as a penalty, in an amount equal to one (1.0%) pecent of the amount of the Investor’s
investment held by the Investor at the time such payment obligation arises (and provided such shares are not otherwise salable
pursuant to Rule 144), for each thirty (30) day period (or pro rata for any portion thereof) following the Filing Date or Effectiveness
Date, as applicable, provided that in no event shall the aggregate liquidated damages paid pursuant to this Section 1.2(b) exceed
six (6%) percent. Such payments shall constitute the Seller’s exclusive remedy for such occurrences. Such payments shall
be made to Investor in cash or Common Stock no later than thirty (30) days following the end of each thirty (30) day period, at
Company’s option, and in the event payment is made in Common Stock, such issuances shall be based upon the 30 day VWAP (as
reported on Bloomberg) for the Common Stock through the date that is one (1) day prior to the date upon which such payment obligation
arises. The Company shall not be obligated to pay any liquidated damages if the Company is unable to fulfill its registration obligations
as a result of rules, regulations, positions or releases issued or actions taken by the Commission pursuant to its authority with
respect to Rule 415, and the Company registers at such time the maximum number of shares of Common Stock permissible upon consultation
with the staff of the Commission. 

 

(c)                
If during the Effectiveness Period, the number of Registrable Securities at any time exceeds
100% of the number of shares of Common Stock then registered on the Registration Statement, the Company shall file as soon as reasonably
practicable an additional registration statement covering the resale of not less than the number of such Registrable Securities.

     

     

    
 

(d)                
The Company shall bear and pay all expenses incurred in connection with any registration,
filing or qualification of Registrable Securities pursuant to this Section 1.2 for each Investor, including (without limitation)
all registration, filing and qualification fees, printer’s fees, accounting fees and fees and disbursements of counsel for
the Company, but excluding any brokerage or underwriting fees, discounts and commissions relating to Registrable Securities and
fees and disbursements of counsel for the Investors.

(e)                
If at any time during the Effectiveness Period there is not an effective Registration Statement
covering all of the Registrable Securities, then the Company shall notify each Investor in writing at least fifteen (15) days prior
to the filing of any registration statement under the Securities Act, in connection with a public offering of shares of Common
Stock (including, but not limited to, registration statements relating to secondary offerings of securities of the Company but
excluding any registration statements (i) on Form S-4 or S-8 (or any successor or substantially similar form), or of any employee
stock option, stock purchase or compensation plan or of securities issued or issuable pursuant to any such plan, or a dividend
reinvestment plan, (ii) otherwise relating to any employee, benefit plan or corporate reorganization or other transactions covered
by Rule 145 promulgated under the Securities Act, (iii) on any registration form which does not permit secondary sales or does
not include substantially the same information as would be required to be included in a registration statement covering the resale
of the Registrable Securities. In the event an Investor desires to include in any such registration statement all or any part of
the Registrable Securities held by such Investor, the Investor shall within ten (10) days after the above-described notice from
the Company, so notify the Company in writing, including the number of such Registrable Securities such Investor wishes to include
in such registration statement. If an Investor decides not to include all of its Registrable Securities in any registration statement
thereafter filed by the Company such Investor shall nevertheless continue to have the right to include any of its Registrable Securities
in any subsequent registration statement or registration statements as may be filed by the Company with respect to the offering
of its securities, all upon the terms and conditions set forth herein.

1.3             
Obligations of the Company. Whenever required under this Section 1 to effect
the registration of any Registrable Securities, the Company shall, as expeditiously as reasonably possible:

(a)                
Prepare and file with the Commission the Registration Statement and use its reasonable best
efforts to cause such Registration Statement to become effective and to keep such Registration Statement effective during the Effectiveness
Period;

(b)                
Prepare and file with the Commission such amendments and supplements to such Registration
Statement and the prospectus used in connection with such Registration Statement as may be necessary to comply with the provisions
of the Securities Act with respect to the disposition of all securities covered by such Registration Statement;

(c)                
Furnish to the Investors such numbers of copies of a prospectus in conformity with the requirements
of the Securities Act, and such other documents as they may reasonably request in order to facilitate the disposition of Registrable
Securities owned by them (provided that the Company shall not be required to print such prospectuses if readily available to Investors
from any electronic service, such as on the EDGAR filing database maintained at www.sec.gov);

(d)                
Use its reasonable best efforts to register and qualify the securities covered by such Registration
Statement under such other securities’ or blue sky laws of such jurisdictions as shall be reasonably requested by the Investors;
provided that the Company shall not be required in connection therewith or as a condition thereto to qualify to do business or
to file a general consent to service of process in any such states or jurisdictions;

(e)                
In the event of any underwritten public offering, enter into and perform its obligations under
an underwriting agreement, in usual and customary form, with the managing underwriter(s) of such offering (each Investor participating
in such underwriting shall also enter into and perform its obligations under such an agreement);

     

     

    
 

(f)                 
Promptly notify each Investor holding Registrable Securities covered by the Registration Statement
at any time when a prospectus relating thereto is required to be delivered under the Securities Act, within one business day, (i)
of the effectiveness of such Registration Statement, or (ii) of the occurrence of any event as a result of which the prospectus
included in such Registration Statement, as then in effect, includes an untrue statement of a material fact or omits to state a
material fact required to be stated therein or necessary to make the statements therein not misleading in the light of the circumstances
then existing;

(g)                
Cause all such Registrable Securities registered pursuant hereto to be listed on each securities
exchange or nationally recognized quotation system on which similar securities issued by the Company are then listed; and

(h)                
Provide a transfer agent and registrar for all Registrable Securities registered pursuant
hereunder and a CUSIP number for all such Registrable Securities, in each case not later than the effective date of such registration.

1.4             
Furnish Information. It shall be a condition precedent to the Company’s obligations
to take any action pursuant to this Section 1 with respect to the Registrable Securities of any Investor that such Investor
shall furnish to the Company such information regarding such Investor, the Registrable Securities held by such Investor, and the
intended method of disposition of such securities in the form attached to this Agreement as Annex B, or as otherwise reasonably
required by the Company or the managing underwriters, if any, to effect the registration of such Investor’s Registrable Securities.

1.5             
Delay of Registration. No Investor shall have any right to obtain or seek an injunction
restraining or otherwise delaying any such registration as the result of any controversy that might arise with respect to the interpretation
or implementation of this Section 1.

1.6             
Indemnification.

(a)                
To the extent permitted by law, the Company will indemnify and hold harmless each Investor,
any underwriter (as defined in the Securities Act) for such Investor and each person, if any, who controls such Investor or underwriter
within the meaning of the Securities Act or the Exchange Act, against any losses, claims, damages or liabilities (joint or several)
to which any of the foregoing persons may become subject under the Securities Act, the Exchange Act or other federal or state securities
law, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon any
of the following statements, omissions or violations (collectively, a “Violation”): (i) any untrue statement
or alleged untrue statement of a material fact contained in a registration statement, including any preliminary prospectus or final
prospectus contained therein or any amendments or supplements thereto (collectively, the “Filings”), (ii) the
omission or alleged omission to state in the Filings a material fact required to be stated therein, or necessary to make the statements
therein not misleading, or (iii) any violation or alleged violation by the Company of the Securities Act, the Exchange Act, any
state securities law or any rule or regulation promulgated under the Securities Act, the Exchange Act or any state securities law;
and the Company will pay any legal or other expenses reasonably incurred by any person to be indemnified pursuant to this Section
1.6(a) in connection with investigating or defending any such loss, claim, damage, liability or action; provided, however,
that the indemnity agreement contained in this Section 1.6(a) shall not apply to amounts paid in settlement of any such
loss, claim, damage, liability or action if such settlement is effected without the consent of the Company (which consent shall
not be unreasonably withheld), nor shall the Company be liable in any such case for any such loss, claim, damage, liability or
action to the extent that it arises out of or is based upon a Violation that occurs in reliance upon and in conformity with written
information furnished expressly for use in connection with such registration by any such Investor, underwriter or controlling person.

(b)                
To the extent permitted by law, each Investor will indemnify and hold harmless the Company,
each of its directors, each of its officers who has signed the registration statement, each person, if any, who controls the Company
within the meaning of the Securities Act or the Exchange Act, any underwriter, any other Investor selling securities in such registration
statement and any controlling person of any such underwriter or other Investor, against any losses, claims, damages or liabilities
(joint or several) to which any of the foregoing persons may become subject under the Securities Act, the Exchange Act or other
federal or state securities law, insofar as such losses, claims, damages or liabilities (or actions in respect thereto) arise out
of or are based upon any Violation, in each case to the extent (and only to the extent) that such Violation occurs in reliance
upon and in conformity with written information furnished by such Investor expressly for use in connection with such registration;
and each such Investor will pay any legal or other expenses reasonably incurred by any person to be indemnified pursuant to this
Section 1.6(b) in connection with investigating or defending any such loss, claim, damage, liability or action; provided,
however, that the indemnity agreement contained in this Section 1.6(b) shall not apply to amounts paid in settlement
of any such loss, claim, damage, liability or action if such settlement is effected without the consent of the Investor (which
consent shall not be unreasonably withheld); provided, however, in no event shall any indemnity under this Section
1.6(b) exceed the net proceeds received by such Investor upon the sale of the Registrable Securities giving rise to such indemnification
obligation.

     

     

    
 

(c)                
Promptly after receipt by an indemnified party under this Section 1.6 of notice of
the commencement of any action (including any governmental action), such indemnified party will, if a claim in respect thereof
is to be made against any indemnifying party under this Section 1.6, deliver to the indemnifying party a written notice
of the commencement thereof and the indemnifying party shall have the right to participate in, and, to the extent the indemnifying
party so desires, jointly with any other indemnifying party similarly noticed, to assume the defense thereof with counsel mutually
satisfactory to the parties; provided, however, that an indemnified party (together with all other indemnified parties
that may be represented without conflict by one counsel) shall have the right to retain one separate counsel, with the fees and
expenses to be paid by the indemnifying party, if representation of such indemnified party by the counsel retained by the indemnifying
party would be inappropriate due to actual or potential differing interests between such indemnified party and any other party
represented by such counsel in such proceeding. The failure to deliver written notice to the indemnifying party within a reasonable
time of the commencement of any such action, if materially prejudicial to its ability to defend such action, shall relieve such
indemnifying party of any liability to the indemnified party under this Section 1.6, but the omission so to deliver written
notice to the indemnifying party will not relieve it of any liability that it may have to any indemnified party otherwise than
under this Section 1.6.

(d)                
If the indemnification provided for in Section 1.6(a) or Section 1.6(b) is held
by a court of competent jurisdiction to be unavailable to an indemnified party with respect to any loss, claim, damage or expense
referred to herein, then the indemnifying party, in lieu of indemnifying such indemnified party hereunder, shall contribute to
the amount paid or payable by such indemnified party as a result of such loss, claim, damage or expense in such proportion as is
appropriate to reflect the relative fault of the indemnifying party on the one hand and of the indemnified party on the other in
connection with the statements or omissions or alleged statements or omissions that resulted in such loss, liability, claim or
expense as well as any other relevant equitable considerations. The relative fault of the indemnifying party and of the indemnified
party shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact
relates to information supplied by the indemnifying party or by the indemnified party and the parties’ relative intent, knowledge,
access to information and opportunity to correct or prevent such statement or omission. In no event shall any Investor be required
to contribute an amount in excess of the net proceeds received by such Investor upon the sale of the Registrable Securities giving
rise to such indemnification obligation.

1.7             
Reports Under Securities Exchange Act. With a view to making available the benefits
of certain rules and regulations of the Commission, including Rule 144, that may at any time permit an Investor to sell securities
of the Company to the public without registration or pursuant to a registration on Form S-1 or Form S-3, the Company agrees to:

(a)                
make and keep public information available, as those terms are understood and defined in Rule
144, for a period of no less than two (2) years following the Final Closing Date;

(b)                
take such action as is necessary to enable the Investors to utilize Form S-1 for the sale
of their Registrable Securities, such action to be taken as soon as practicable after the end of the fiscal year in which the registration
statement is declared effective; and

(c)                
file with the Commission in a timely manner all reports and other documents required of the
Company under the Securities Act and the Exchange Act.

     

     

    
 

1.8             
Transfer or Assignment of Registration Rights. The rights to cause the Company to register
Registrable Securities pursuant to this Section 1 may be transferred or assigned, but only with all related obligations, by an
Investor to a transferee or assignee who acquires at least 25,000 Registrable Securities (subject to appropriate adjustment for
stock splits, stock dividends and combinations) from such transferring Investor, unless waived in writing by the Company; provided,
that (i) prior to such transfer or assignment, the Company is furnished with written notice stating the name and address of such
transferee or assignee and identifying the securities with respect to which such registration rights are being transferred or assigned,
(ii) such transferee or assignee agrees in writing to be bound by and subject to the terms and conditions of this Agreement and
(iii) such transfer or assignment shall be effective only if immediately following such transfer or assignment the further disposition
of such securities by the transferee or assignee is restricted under the Securities Act.

2.      
Miscellaneous.

2.1             
Governing Law. The parties hereby agree that any dispute which may arise between them
arising out of or in connection with this Agreement shall be adjudicated only before a federal court located in the State of New
York and they hereby submit to the exclusive jurisdiction of the federal and state courts of the State of New York with respect
to any action or legal proceeding commenced by any party, and irrevocably waive any objection they now or hereafter may have respecting
the venue of any such action or proceeding brought in such a court or respecting the fact that such court is an inconvenient forum,
relating to or arising out of this Agreement or any acts or omissions relating to the registration of the securities hereunder,
and consent to the service of process in any such action or legal proceeding by means of registered or certified mail, return receipt
requested, in care of the address set forth below or such other address as the undersigned shall furnish in writing to the other.

2.2             
WAIVER OF JURY TRIAL. IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY
ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE
LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY

2.3             
Waivers and Amendments. This Agreement may be terminated and any term of this Agreement
may be amended or waived (either generally or in a particular instance and either retroactively or prospectively) with the written
consent of the Company and Investors holding at least a majority of the Registrable Securities then outstanding (the “Majority
Investors”). Any termination, amendment or waiver effected in accordance with this Section 2.3 shall be binding
upon each holder of Registrable Securities then outstanding, each future holder of all such Registrable Securities and the Company.

2.4             
Successors and Assigns. Except as otherwise expressly provided herein, the provisions
of this Agreement shall inure to the benefit of, and be binding upon, the successors, assigns, heirs, executors and administrators
of the parties hereto.

2.5             
Entire Agreement. This Agreement constitutes the full and entire understanding and
agreement among the parties with regard to the subject matter hereof, and no party shall be liable or bound to any other party
in any manner by any warranties, representations or covenants except as specifically set forth herein.

2.6             
Notices. All notices and other communications required or permitted under this Agreement
shall be in writing and shall be delivered personally by hand or by overnight courier, mailed by United States first-class mail,
postage prepaid, sent by facsimile or sent by electronic mail directed (a) if to an Investor, at such Investor’s address,
facsimile number or electronic mail address set forth in the Company’s records, or at such other address, facsimile number
or electronic mail address as such Investor may designate by ten (10) days’ advance written notice to the other parties hereto
or (b) if to the Company, to its address, facsimile number or electronic mail address set forth on its signature page to this Agreement
and directed to the attention of its President, or at such other address, facsimile number or electronic mail address as the Company
may designate by ten (10) days’ advance written notice to the other parties hereto. All such notices and other communications
shall be effective or deemed given upon delivery, on the date that is three (3) days following the date of mailing, upon confirmation
of facsimile transfer or upon confirmation of electronic mail delivery.

2.7             
Interpretation. The words “include,” “includes” and “including”
when used herein shall be deemed in each case to be followed by the words “without limitation.” The titles and subtitles
used in this Agreement are used for convenience only and are not considered in construing or interpreting this Agreement.

     

     

    
 

2.8             
Severability. If one or more provisions of this Agreement are held to be unenforceable
under applicable law, such provision shall be excluded from this Agreement, and the balance of the Agreement shall be interpreted
as if such provision were so excluded, and shall be enforceable in accordance with its terms.

2.9             
Independent Nature of Investors’ Obligations and Rights. The obligations of each
Investor hereunder are several and not joint with the obligations of any other Investor hereunder, and no Investor shall be responsible
in any way for the performance of the obligations of any other Investor hereunder. Nothing contained herein or in any other agreement
or document delivered at any closing, and no action taken by any Investor pursuant hereto or thereto, shall be deemed to constitute
the Investors as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Investors
are in any way acting in concert with respect to such obligations or the transactions contemplated by this Agreement. Each Investor
shall be entitled to protect and enforce its rights, including without limitation the rights arising out of this Agreement, and
it shall not be necessary for any other Investor to be joined as an additional party in any proceeding for such purpose.

2.10          
Counterparts. This Agreement may be executed in any number of counterparts, each of
which shall be an original, but all of which together shall constitute one instrument.

2.11          
Telecopy Execution and Delivery. A facsimile, telecopy or other reproduction of this
Agreement may be executed by one or more parties hereto, and an executed copy of this Agreement may be delivered by one or more
parties hereto by facsimile or similar electronic transmission device pursuant to which the signature of or on behalf of such party
can be seen, and such execution and delivery shall be considered valid, binding and effective for all purposes. At the request
of any party hereto, all parties hereto agree to execute an original of this Agreement as well as any facsimile, telecopy or other
reproduction hereof.

[SIGNATURE PAGE
FOLLOWS]

     

     

    

IN WITNESS WHEREOF,
the Company has caused this Agreement to be executed by its duly authorized officer, as of the date, month and year first set forth
above.

“Company”

AMERICAN STRATEGIC MINERALS CORP.

 

By:________________________________

Name: Doug Croxall

Title: Chief Executive Officer

Address for notice:

 

2331 Mill Road, Suite 100

Alexandria, VA 22314

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

[COMPANY SIGNATURE PAGE TO REGISTRATION RIGHTS
AGREEMENT]

     

     

    

 

IN WITNESS WHEREOF,
the undersigned Investor has executed this Agreement as of the date, month and year that such Investor became the owner of Registrable
Securities.

“Investor”

___________________________________

By:________________________________

Name

Title:

 

Address:

___________________________________

 

___________________________________

___________________________________

Telephone:__________________________

Facsimile:___________________________

 

Email:______________________________

 

 

 

 

 

 

 

 

 

 

 

 

 

 

[INVESTOR COUNTERPART SIGNATURE PAGE TO 

REGISTRATION RIGHTS AGREEMENT]

     

     

    

Annex A

Plan of Distribution

 

Each selling stockholder
of the common stock and any of their pledgees, assignees and successors-in-interest may, from time to time, sell any or all of
their shares of common stock on the Over-the-Counter Bulletin Board or any other stock exchange, market or trading facility on
which the shares are traded or in private transactions. These sales may be at fixed or negotiated prices. A selling stockholder
may use any one or more of the following methods when selling shares:

		·	ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;

		·	block trades in which the broker-dealer will attempt to sell the shares as agent but may position
and resell a portion of the block as principal to facilitate the transaction; 

		·	purchases by a broker-dealer as principal and resale by the broker-dealer for its account; 

		·	an exchange distribution in accordance with the rules of the applicable exchange; 

		·	privately negotiated transactions; 

		·	settlement of short sales entered into after the effective date of the registration statement
of which this prospectus is a part; 

		·	broker-dealers may agree with the selling stockholders to sell a specified number of such shares
at a stipulated price per share; 

		·	through the writing or settlement of options or other hedging transactions, whether through an
options exchange or otherwise; 

		·	a combination of any such methods of sale; or 

		·	any other method permitted pursuant to applicable law. 

The selling stockholders
may also sell shares under Rule 144 under the Securities Act of 1933, as amended, if available, rather than under this prospectus.

Broker-dealers engaged
by the selling stockholders may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions
or discounts from the selling stockholders (or, if any broker-dealer acts as agent for the purchaser of shares, from the purchaser)
in amounts to be negotiated, but, except as set forth in a supplement to this prospectus, in the case of an agency transaction
not in excess of a customary brokerage commission in compliance with FINRA Rule 2440; and in the case of a principal transaction
a markup or markdown in compliance with FINRA IM-2440.

In connection with
the sale of the common stock or interests therein, the selling stockholders may enter into hedging transactions with broker-dealers
or other financial institutions, which may in turn engage in short sales of the common stock in the course of hedging the positions
they assume. The selling stockholders may also sell shares of the common stock short and deliver these securities to close out
their short positions, or loan or pledge the common stock to broker-dealers that in turn may sell these securities. The selling
stockholders may also enter into option or other transactions with broker-dealers or other financial institutions or the creation
of one or more derivative securities which require the delivery to such broker-dealer or other financial institution of shares
offered by this prospectus, which shares such broker-dealer or other financial institution may resell pursuant to this prospectus
(as supplemented or amended to reflect such transaction).

     

     

    
 

The selling stockholders
and any broker-dealers or agents that are involved in selling the shares may be deemed to be “underwriters” within
the meaning of the Securities Act of 1933, as amended, in connection with such sales. In such event, any commissions received by
such broker-dealers or agents and any profit on the resale of the shares purchased by them may be deemed to be underwriting commissions
or discounts under the Securities Act of 1933, as amended. Each selling stockholder has informed us that it does not have any written
or oral agreement or understanding, directly or indirectly, with any person to distribute the common stock. In no event shall any
broker-dealer receive fees, commissions and markups which, in the aggregate, would exceed eight percent (8%).

We are required
to pay certain fees and expenses incurred by us incident to the registration of the shares. We have agreed to indemnify the selling
stockholders against certain losses, claims, damages and liabilities, including liabilities under the Securities Act of 1933, as
amended.

Because selling
stockholders may be deemed to be “underwriters” within the meaning of the Securities Act of 1933, as amended, they
will be subject to the prospectus delivery requirements of the Securities Act of 1933, as amended, including Rule 172 thereunder.
In addition, any securities covered by this prospectus which qualify for sale pursuant to Rule 144 under the Securities Act of
1933, as amended may be sold under Rule 144 rather than under this prospectus. There is no underwriter or coordinating broker acting
in connection with the proposed sale of the resale shares by the selling stockholders.

We agreed to keep
this prospectus effective until the earlier of (i) the date on which the shares may be resold by the selling stockholders without
registration and without the requirement to be in compliance with Rule 144(c)(1) and otherwise without restriction or limitation
pursuant to Rule 144 or (ii) all of the shares have been sold pursuant to this prospectus or Rule 144 under the Securities Act
or any other rule of similar effect. The resale shares will be sold only through registered or licensed brokers or dealers if required
under applicable state securities laws. In addition, in certain states, the resale shares may not be sold unless they have been
registered or qualified for sale in the applicable state or an exemption from the registration or qualification requirement is
available and is complied with.

Under applicable
rules and regulations under the Securities Exchange Act of 1934, as amended, any person engaged in the distribution of the resale
shares may not simultaneously engage in market making activities with respect to the common stock for the applicable restricted
period, as defined in Regulation M, prior to the commencement of the distribution. In addition, the selling stockholders will be
subject to applicable provisions of the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder,
including Regulation M, which may limit the timing of purchases and sales of shares of the common stock by the selling stockholders
or any other person. We will make copies of this prospectus available to the selling stockholders and have informed them of the
need to deliver a copy of this prospectus to each purchaser at or prior to the time of the sale (including by compliance with Rule
172 under the Securities Act of 1933, as amended).

     

     

    

Annex B

AMERICAN STRATEGIC MINERALS CORP

Selling Securityholder Notice and Questionnaire

 

The undersigned
beneficial owner of common stock (the “Registrable Securities”) of American Strategic Minerals Corp.,
a Nevada corporation (the “Company”), understands that the Company has filed or intends
to file with the Securities and Exchange Commission (the “Commission”) a registration statement (the “Registration
Statement”) for the registration and resale under Rule 415 of the Securities Act of 1933, as amended (the “Securities
Act”), of the Registrable Securities, in accordance with the terms of the Registration Rights Agreement (the “Registration
Rights Agreement”) to which this document is annexed. A copy of the Registration Rights Agreement is available from the
Company upon request at the address set forth below. All capitalized terms not otherwise defined herein shall have the meanings
ascribed thereto in the Registration Rights Agreement.

 

Certain legal consequences arise from being
named as a selling securityholder in the Registration Statement and the related prospectus. Accordingly, holders and beneficial
owners of Registrable Securities are advised to consult their own securities law counsel regarding the consequences of being named
or not being named as a selling securityholder in the Registration Statement and the related prospectus.

 

NOTICE

 

The undersigned beneficial owner (the “Selling
Securityholder”) of Registrable Securities hereby elects to include the Registrable Securities owned by it in the Registration
Statement.

 

The undersigned hereby provides the following information to the
Company and represents and warrants that such information is accurate:

 

QUESTIONNAIRE

 

1.Name.

 

(a)Full Legal Name of Selling Securityholder

 

_____________________________________________________________________________________________

 

(b)Full Legal Name of Registered Holder
(if not the same as (a) above) through which Registrable Securities are held:

 

_____________________________________________________________________________________________

 

(c)Full Legal Name of Natural Control Person
(which means a natural person who directly or indirectly alone or with others has power to vote or dispose of the securities covered
by this Questionnaire):

 

2.Address for Notices to Selling Securityholder:

_____________________________________________________________________________________________

_____________________________________________________________________________________________

_____________________________________________________________________________________________

 

	Telephone:
	Fax:
	Contact Person:

 

3.Broker-Dealer Status:

 

(a)Are you a broker-dealer?

 

Yes         No

 

     

     

    
 

(b)If “yes” to Section 3(a),
did you receive your Registrable Securities as compensation for investment banking services to the Company?

 

Yes         No

 

Note:If “no” to Section 3(b),
the Commission’s staff has indicated that you should be identified as an underwriter in the Registration Statement.

 

(c)Are you an affiliate of a broker-dealer?

 

Yes         No

 

(d)If you are an affiliate of a broker-dealer,
do you certify that you purchased the Registrable Securities in the ordinary course of business, and at the time of the purchase
of the Registrable Securities to be resold, you had no agreements or understandings, directly or indirectly, with any person to
distribute the Registrable Securities?

 

Yes         No

 

Note:If “no” to Section 3(d),
the Commission’s staff has indicated that you should be identified as an underwriter in the Registration Statement.

 

4. Beneficial Ownership of Securities of the Company Owned by
the Selling Securityholder.

 

Except as set forth below in this Item 4,
the undersigned is not the beneficial or registered owner of any securities of the Company other than the securities issuable pursuant
to the Purchase Agreement.

 

 

 

(a)Type and Amount of other securities
beneficially owned by the Selling Securityholder:

   

_____________________________________________________________________________________________

_____________________________________________________________________________________________

 

5. Relationships with the Company:

 

Except as set forth below, neither the undersigned
nor any of its affiliates, officers, directors or principal equity holders (owners of 5% of more of the equity securities of the
undersigned) has held any position or office or has had any other material relationship with the Company (or its predecessors or
affiliates) during the past three years.

 

State any exceptions here:

_____________________________________________________________________________________________

_____________________________________________________________________________________________

 

The undersigned agrees to promptly notify the
Company of any inaccuracies or changes in the information provided herein that may occur subsequent to the date hereof at any time
while the Registration Statement remains effective.

 

By signing below, the undersigned consents
to the disclosure of the information contained herein in its answers to Items 1 through 5 and the inclusion of such information
in the Registration Statement and the related prospectus and any amendments or supplements thereto. The undersigned understands
that such information will be relied upon by the Company in connection with the preparation or amendment of the Registration Statement
and the related prospectus.

 

     

     

    
 

IN WITNESS WHEREOF the undersigned, by authority
duly given, has caused this Notice and Questionnaire to be executed and delivered either in person or by its duly authorized agent.

 

Date:

 

Beneficial Owner:

 

By:_________________________________

       Name:

       Title:

 

[SIGNATURE PAGE FOR SELLING SECURITYHOLDER
NOTICE AND QUESTIONNAIRE]

 

PLEASE FAX A COPY OF THE COMPLETED AND EXECUTED
NOTICE AND QUESTIONNAIRE, AND RETURN THE ORIGINAL BY OVERNIGHT MAIL, TO:

 

American Strategic
Minerals Corp.

 

Attn: Chief Executive Officer

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00211-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00211-of-00352.parquet"}]]